Molecular Neuroimaging

Fig.1
MRI 3D

Our efforts to understand complex cellular networks such as those that make up our brains are greatly aided by in vivo measurement methods that can resolve cellular activity at the molecular level across entire organs of intact subjects. The research group Molecular Neuroimaging is thus focused on developing molecule-specific and responsive contrast agents that translate key cellular events to dynamic signals, which can be read out by non-invasive imaging technology such as Magnetic Resonance. These molecular contrast agent sensors are fabricated through genetic and protein engineering, chemistry and nanotechnological methods. They are then validated in vivo via multimodal imaging approaches in close collaboration with the Institute of Biological and Medical Imaging and the University Hospital of Technische Universität München. In conjunction with high-resolution fMRI and advanced optical methods we employ these responsive neuroimaging agents to study neuronal network function in rodent models of neuropsychiatric disease.

 

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Only cookies permitted that are required for the basic functionality of our websites.
Permit cookies that help us to analyse the page views and user behavior on our websites. We only use this information for improving our services.
Permit embedded content and cookies from third party providers. This setting enables the full use of our web services (e.g. displaying videos).
Please find more information in our privacy statement.

There you may also change your settings later.